RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Flu cases in Queensland in the past six months now outnumber the total recorded over the same period last year – and doctors ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Influenza has killed 235 Albertans in the last 10 months, the most deaths since 2009. The CBC's Jennifer Lee looks at some ...

When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...

Two people have died of the highly infectious influenza in a fortnight as the WA Health Minister Meredith Hammat described ...

Flu cases in Queensland in the past six months now outnumber the total recorded in 2024 – and doctors warn the worst is yet ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...